propranolol/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“There were no significant differences between propranolol and placebo/usual care with respect to mortality (RD −0.02 [95% CI −0.06 to 0.02]), and also, no differences were found in the sub-group analysis when assessing this outcome in children (RD −0.02 [95% CI −0.06 to 0.02]) and adults (RD −0.05 [95% CI −0.17 to 0.07]).”
Quoted verbatim from Safety and effectiveness of propranolol in severely burned patients: systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- Severely burned adults and children (TBSA >20%) in randomised trials of propranolol versus placebo or usual care; four trials reported mortality
Safety and effectiveness of propranolol in severely burned patients: systematic review and meta-analysis.2017PMID:28265298Permalink
Keep reading
- Everything the graph holds on propranolol
- Every compound studied against All-cause mortality
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4523B2KJK3CWZJ86K2G6NXN